Onxeo S.A.: Onxeo: Combined General Meeting of June 6, 2023:

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and

Related Keywords

Paris , France General , France , Onxeo Sa Euronext , Onis Onxeo , Arthur Rouill , Nicolas Fossiez , Gewinn Nur , Raymond Poincar , Renaissance Paris Nobel Tour Eiffel Hotel , Company Group , Regulatory News , Euronext Growth Paris , Combined General Meeting , General Meeting , General Meetings , Investor Relations , Onxeo , Combined , Eneral , Meeting , Pune , 023 , Availability , Preparatory , Documents , Participation , Voting , Procedures ,